Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting

NEXT STORY
Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods
PREV STORY
Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBL Presents New Data on the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Rheumatoid Arthritis at the EULAR 2020 Congress

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference

author_avatar
NASDAQ Market News

GeoVax Presenting at Upcoming October European Scientific Conferences

author_avatar
NASDAQ Market News